Vanguard Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.5M | Buy |
4,841,500
+547,096
| +13% | +$7.17M | ﹤0.01% | 2023 |
|
|
2025
Q1 | $94.5M | Sell |
4,294,404
-172,445
| -4% | -$3.79M | ﹤0.01% | 1824 |
|
|
2024
Q4 | $119M | Sell |
4,466,849
-49,214
| -1% | -$1.31M | ﹤0.01% | 1792 |
|
|
2024
Q3 | $121M | Buy |
4,516,063
+7,897
| +0.2% | +$211K | ﹤0.01% | 1785 |
|
|
2024
Q2 | $81.2M | Buy |
4,508,166
+490,733
| +12% | +$8.84M | ﹤0.01% | 1936 |
|
|
2024
Q1 | $73.3M | Buy |
4,017,433
+1,892,053
| +89% | +$34.5M | ﹤0.01% | 2014 |
|
|
2023
Q4 | $23.3M | Buy |
2,125,380
+60,959
| +3% | +$667K | ﹤0.01% | 2525 |
|
|
2023
Q3 | $11.8M | Buy |
2,064,421
+32,462
| +2% | +$186K | ﹤0.01% | 2783 |
|
|
2023
Q2 | $15.7M | Buy |
2,031,959
+26,134
| +1% | +$203K | ﹤0.01% | 2695 |
|
|
2023
Q1 | $13.4M | Buy |
2,005,825
+22,821
| +1% | +$152K | ﹤0.01% | 2787 |
|
|
2022
Q4 | $17.7M | Buy |
1,983,004
+231,159
| +13% | +$2.07M | ﹤0.01% | 2676 |
|
|
2022
Q3 | $17.2M | Buy |
1,751,845
+525,277
| +43% | +$5.17M | ﹤0.01% | 2699 |
|
|
2022
Q2 | $9.76M | Buy |
1,226,568
+15,475
| +1% | +$123K | ﹤0.01% | 3001 |
|
|
2022
Q1 | $11.7M | Buy |
1,211,093
+11,693
| +1% | +$113K | ﹤0.01% | 3067 |
|
|
2021
Q4 | $18.3M | Buy |
1,199,400
+611,879
| +104% | +$9.35M | ﹤0.01% | 2886 |
|
|
2021
Q3 | $9.75M | Buy |
587,521
+4,658
| +0.8% | +$77.3K | ﹤0.01% | 3258 |
|
|
2021
Q2 | $12.4M | Buy |
582,863
+462,863
| +386% | +$9.87M | ﹤0.01% | 3097 |
|
|
2021
Q1 | $3.9M | Buy |
+120,000
| New | +$3.9M | ﹤0.01% | 3656 |
|